News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

Fluvoxamine wins, metformin disappoints in long COVID fatigue
18 hours ago
byElvira Manzano
The antidepressant fluvoxamine reduces long COVID fatigue, whereas the antidiabetic agent metformin fails to outperform placebo in the randomized REVIVE-TOGETHER trial.
Fluvoxamine wins, metformin disappoints in long COVID fatigue
18 hours ago
COVID-19 vaccine improves survival outcomes in cancer patients on ICI therapy
17 Jun 2026
byStephen Padilla
Vaccination against COVID-19 provides survival benefits to cancer patients receiving immune checkpoint inhibitors (ICIs), as shown in a recent study.







